Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01024907 · ClinicalTrials.gov registry record · Phase 1
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas
A Phase 1 study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT01024907 is a Phase 1 study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 23 participants.
The verdict
NCT01024907, a Phase 1 study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
RATIONALE: Specialized radiation therapy, such as proton beam radiation therapy, that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studying the best way to give proton beam radiation therapy and to see how well it works in treating patients with low grade gliomas.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- RADIATION proton beam radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-12-17 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01024907
The ClinicalTrials.gov registry entry for NCT01024907 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01024907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01024907 about?
NCT01024907 is a clinical study titled "Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas". RATIONALE: Specialized radiation therapy, such as proton beam radiation therapy, that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase I/II trial is studying the best way to give proton beam radiation thera...
What is the current status of trial NCT01024907?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2009-12-17. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01024907?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), proton beam radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01024907?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.